saRNA Synthesis Service Market Size & Share Analysis 2032: Key Trends According to a newly published market research report by 24LifeSciences, global saRNA synthesis service market was valued at USD 1159 million in 2024 and is projected to reach USD 2413 million by 2031, growing at a compound annual growth rate (CAGR) of 11.4% during the forecast period 2025-2031. Self-amplifying RNA (saRNA) represents a novel class of synthetic RNA that replicates autonomously in host cells, enabling amplified expression of target proteins. This innovative technology retains key advantages of conventional mRNA platformsincluding rapid development timelines, modular design capabilities, and cell-free synthesisbut its self-replicating mechanism requires significantly lower doses, typically 10-100 times less than standard mRNA. This reduction in required material translates to substantially lower production costs and improved safety profiles, making it particularly transformative for vaccine development, gene therapy, and a wide array of therapeutic applications. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3991/sarna-synthesis-service-market

Global DNA Transfection Kits Market Forecast 2025: Revenue Insights According to a newly published market research report by 24LifeSciences, global DNA transfection kits market was valued at USD 166 million in 2024 and is projected to reach USD 241 million by 2031, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period 2024-2031. A DNA transfection kit is an essential laboratory tool used to introduce exogenous DNA into cells. These kits contain specialized chemicals or carriers designed to improve transfection efficiency and cell survival rates. They are widely used across multiple fields including gene function research, gene therapy development, biopharmaceutical production, and various cellular biology applications. The technology enables researchers to study gene expression, protein production, and cellular mechanisms with greater precision and reproducibility. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5111/dna-transfection-kits-market

Global Gene Therapy Market to Reach USD 50.34 Billion by 2032 | CAGR 29.9% According to a newly published market research report by 24LifeSciences, global gene therapy market was valued at USD 8.40 billion in 2024 and is projected to reach USD 50.34 billion by 2031, growing at a compound annual growth rate (CAGR) of 29.9% during the forecast period 2025-2031. Gene therapy represents a revolutionary medical approach that involves modifying a persons genes to treat or prevent disease. It typically employs vectors, often engineered viruses, to deliver functional genetic material into cells to correct defective genes, regulate gene expression, or introduce new functions. While still an emerging field, its potential to provide durable, even curative, treatments for a range of genetic, oncologic, and rare diseases is driving unprecedented investment and innovation across the global healthcare sector. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1604/gene-therapy-market-market